Cargando…

Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical trial

INTRODUCTION: Proliferative diabetic retinopathy (PDR) is the main cause of severe visual loss in people with diabetes mellitus. The standard treatment for this condition is panretinal photocoagulation (PRP). This laser treatment is inherently destructive, with predictable adverse effects on visual...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sivaprasad, Sobha, Prevost, A Toby, Bainbridge, James, Edwards, Rhiannon Tudor, Hopkins, David, Kelly, Joanna, Luthert, Phil, Murphy, Caroline, Ramu, Jayashree, Sarafraz-Shekary, Negin, Vasconcelos, Joana, White-Alao, Beverley, Hykin, Philip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Ophthalmology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577925/ https://www.ncbi.nlm.nih.gov/pubmed/26369798 http://dx.doi.org/10.1136/bmjopen-2015-008405

Ejemplares similares

Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy
por: Nicholson, Luke, et al.
Publicado: (2018)

Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion: A Randomized Clinical Trial
por: Hykin, Philip, et al.
Publicado: (2019)

Topographical Response of Retinal Neovascularization to Aflibercept or Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: Post Hoc Analysis of the CLARITY Randomized Clinical Trial
por: Halim, Sandra, et al.
Publicado: (2021)

Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting
por: Eleftheriadou, Maria, et al.
Publicado: (2018)

Pegaptanib sodium for neovascular age-related macular degeneration: clinical experience in the UK
por: Sivaprasad, Sobha, et al.
Publicado: (2008)

Health-related quality of life, visual function and treatment satisfaction following intravitreal dexamethasone implant for diabetic macular edema
por: Ramu, Jayashree, et al.
Publicado: (2017)

Predictors of Visual Acuity Outcomes after Anti–Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion
por: Sen, Piyali, et al.
Publicado: (2021)

Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
por: Pennington, Becky, et al.
Publicado: (2021)

Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
por: Pennington, Becky, et al.
Publicado: (2021)

Evaluation of real-world early response of DMO to aflibercept therapy to inform future clinical trial design of novel investigational agents
por: Halim, Sandra, et al.
Publicado: (2020)

Acronyms
Publicado: (2007)

A normative study of acronyms and acronym naming
por: Izura, Cristina, et al.
Publicado: (2011)

A multicentre phase III randomised controlled single-masked clinical trial evaluating the clinical efficacy and safety of light-masks at preventing dark-adaptation in the treatment of early diabetic macular oedema (CLEOPATRA): study protocol for a randomised controlled trial
por: Sivaprasad, Sobha, et al.
Publicado: (2014)

Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trial
por: Sivaprasad, Sobha, et al.
Publicado: (2018)

CERN acronyms
por: Charkiewicz, Andrzej
Publicado: (1999)

Abbreviations and Acronyms
Publicado: (2012)

Acronyms, Shmacronyms
Publicado: (2001)

Acronyms and Abbreviations
Publicado: (2008)

Acronyms and Abbreviations
Publicado: (2006)

Acronyms and Abbreviations
Publicado: (2008)

Acronyms and Abbreviations
Publicado: (2007)

Acronyms and Abbreviations
por: Ribes, Ramón, et al.
Publicado: (2009)

New acronyms and initialisms: 1975 supplement to Acronyms and initialisms dictionary
por: Crocker, Christopher, et al.
Publicado: (1975)

An exploratory study evaluating the effects of macular carotenoid supplementation in various retinal diseases
por: Crosby-Nwaobi, Roxanne, et al.
Publicado: (2016)

No acrimony about acronyms
Publicado: (1977)

Internetworking terms and acronyms
por: Cisco Systems. Menlo Park
Publicado: (1992)

Revised list of acronyms
por: Miyasaka, Nobuyuki
Publicado: (2005)

Aptly coined acronym
por: Devine, C.
Publicado: (2021)

NTC's dictionary of acronyms and abbreviations /
Publicado: (1993)

Dictionary of biomedical acronyms and abbreviations
por: Dupayrat, Jacques
Publicado: (1990)

Dictionary of medical acronyms & abbreviations
Publicado: (1993)

Dictionary of engineering acronyms and abbreviations
por: Keller, Harald
Publicado: (1994)

Glossary of Russian abbreviations and acronyms
por: Library of Congress. Washington, DC
Publicado: (1967)

The growth of acronyms in the scientific literature
por: Barnett, Adrian, et al.
Publicado: (2020)

Acronyms and Abbreviations in Surgery and Medicine
Publicado: (2010)

Part II Acronyms and Abbreviations
por: Gunn, S. William A.
Publicado: (2012)

Simulation and annotation of global acronyms
por: Filimonov, Maxim, et al.
Publicado: (2022)

Summary and conclusions, and abbreviations and acronyms
por: Newhauser, Wayne D., et al.
Publicado: (2023)

Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial
por: Garweg, Justus G., et al.
Publicado: (2022)

The clinical relevance of ultra-widefield angiography findings in patients with central retinal vein occlusion and macular oedema receiving anti-VEGF therapy
por: Nicholson, Luke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p80ofjrveoc0kpqh7kqth1jn2s